NXGL - NEXGEL Inc Growth-Adjusted Payback Ratio

Corporate company logo of nexgel.com (NXGL)

The PEG ratio on the GURU.Markets chart demonstrates the historical dynamics of NEXGEL, Inc. (NXGL), where the value remains at 0.00. Business efficiency is increasing due to the automation of hydrogel production lines. Simultaneously, NEXGEL, Inc. (NXGL) is developing innovative therapeutic patches in collaboration with external partners, maintaining a flawless image as a reliable supplier of transdermal drug delivery systems.

NEXGEL Inc (NXGL): Price/Earnings to Growth Ratio from 07/04/2022 to 11/10/2026
Core merchandise of NEXGEL Inc

Fundamental analysis requires comparing an asset's market value with its earnings dynamics. This indicator is calculated as the P/E ratio relative to earnings growth rates to determine the fairness of the current valuation. By analyzing the PEG ratio, an investor identifies business undervaluation when values fall below one. For NEXGEL, Inc. (NXGL), this is critical, as the scalable production of hydrogel patches sharply reduces costs. Increasing output volumes directly boost margins, making the search for entry points on this chart highly efficient.

Who NEXGEL, Inc. competes with

Price/Earnings to Growth Ratio ISRG (Intuitive Surgical, Inc.)|Danaher Corp - Price/Earnings to Growth Multiple|Growth-Adjusted Payback Ratio BDX|STERIS plc - PEG Multiple|Growth-Adjusted Market Cap to Net Income westpharma.com WST|Baxter (BAX) - Price/Earnings to Growth Ratio|Growth-Adjusted P/E Ratio MASI|Price/Earnings to Growth Ratio Stevanato|Teleflex Corp (TFX) - Growth-Adjusted Market Cap to Net Income|Price/Earnings to Growth Multiple MMSI (Merit Medical Systems)|Company Value to Earnings Growth Ratio NVST|Price/Earnings to Growth Ratio ICU Medical ICUI|Growth-Adjusted Payback Ratio XRAY|LMAT: Price/Earnings to Growth Multiple|ATRC - PEG Multiple|STAAR Surgical Company (STAA) - Price/Earnings to Growth Ratio|Price/Earnings to Growth Multiple ChromaDex|ZIMV (ZimVie) - PEG Multiple|Price to Earnings Adjusted for Growth Rate AngioDynamics Inc ANGO|Price/Earnings to Growth Ratio Cerus Corp (CERS)|Teknova Inc - Growth-Adjusted P/E Ratio|Monogram Technologies - Price/Earnings to Growth Multiple|Company Value to Earnings Growth Ratio STSS (Sharps Technology Inc)|INFU - Price/Earnings to Growth Ratio|Growth-Adjusted Market Cap to Net Income Utah Medical Products Inc. UTMD|korumedical.com (KRMD) - Price/Earnings to Growth Ratio|Growth-Adjusted P/E Ratio NYXH|MBOT (Microbot Medical Inc.) - PEG Multiple|Price to Earnings Adjusted for Growth Rate pro-dex.com PDEX|Price/Earnings to Growth Multiple ZTEK (Zentek)|Elutia Inc - Growth-Adjusted P/E Ratio|PEG Multiple MLSS (Milestone Scientific Corp)|Price to Net Income Growth Ratio Retractable Technologies Inc.|Harvard Bioscience, Inc. - PEG Multiple|Price to Earnings Adjusted for Growth Rate femasys.com|meihuamed.com (MHUA) - Price/Earnings to Growth Ratio|POAI (Predictive Oncology Inc.) - Price/Earnings to Growth Ratio|Price/Earnings to Growth Multiple CJMB|ATRI: Growth-Adjusted Payback Ratio|PEG Multiple NURO